Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TNFAIP3 |
| Upstream (Parents) |
|---|
| (<<) ACAT2 → TNFAIP3 |
| (<<) ACTB → TNFAIP3 |
| (<<) BCL2A1 → TNFAIP3 |
| (<<) BDH1 → TNFAIP3 |
| (<<) ENO3 → TNFAIP3 |
| (<<) MMP12 → TNFAIP3 |
| (<<) MMP19 → TNFAIP3 |
| (<<) MT3 → TNFAIP3 |
| (<<) PDGFB → TNFAIP3 |
| (<<) PTPRE → TNFAIP3 |
| (<<) SMAD2 → TNFAIP3 |
| (<<) SOD1 → TNFAIP3 |
| (<<) STYK1 → TNFAIP3 |
| (<<) TOP2B → TNFAIP3 |
| (<<) UPP1 → TNFAIP3 |
| Downstream (Children) |
|---|
| TNFAIP3 → BCL3 (>>) |
| TNFAIP3 → HDAC4 (>>) |
| TNFAIP3 → INHBA (>>) |
| TNFAIP3 → KLF10 (>>) |
| TNFAIP3 → KLF7 (>>) |
| TNFAIP3 → MTMR6 (>>) |
| TNFAIP3 → N4BP3 (>>) |
| TNFAIP3 → NOS3 (>>) |
